YTB323 clinical trials

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

This study is looking at a new cell therapy called YTB323 for people with a severe type of myasthenia gravis, a muscle weakening condition. It aims to see if it's safe and effective for patients who haven't responded well to other treatments.